Stock Earnings Arcus Biosciences Inc [RCUS] Insider Activity: An Update for Investors Arcus Biosciences Inc’s filing revealed that its Director KANEKO YASUNORI acquired Company’s shares for reported $0.2 million on Feb 27
Analysts Viewpoint Arcus Biosciences Inc [RCUS] Records 200-Day SMA of $13.56 Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Arcus Biosciences
Uncategorized Arcus Biosciences Inc. (NYSE: RCUS) Gets A 50.46% Target Price Upside From Analysts While 21.33% Above Its 52-Week Low Arcus Biosciences Inc. (NYSE:RCUS) does about 1.18M shares in volume on a normal day but saw 853343 shares change hands